USA COMPRESSION PARTNERS LP (USAC) Fundamental Analysis & Valuation

NYSE:USAC • US90290N1090

Current stock price

28.53 USD
+0.28 (+0.99%)
Last:

This USAC fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

6

1. USAC Profitability Analysis

1.1 Basic Checks

  • USAC had positive earnings in the past year.
  • USAC had a positive operating cash flow in the past year.
  • The reported net income has been mixed in the past 5 years: USAC reported negative net income in multiple years.
  • USAC had a positive operating cash flow in each of the past 5 years.
USAC Yearly Net Income VS EBIT VS OCF VS FCFUSAC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M -200M -400M -600M

1.2 Ratios

  • USAC's Return On Assets of 3.93% is fine compared to the rest of the industry. USAC outperforms 68.33% of its industry peers.
  • USAC has a better Return On Invested Capital (10.33%) than 80.00% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for USAC is below the industry average of 13.36%.
  • The last Return On Invested Capital (10.33%) for USAC is above the 3 year average (9.05%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 3.93%
ROE N/A
ROIC 10.33%
ROA(3y)2.56%
ROA(5y)1.12%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)9.05%
ROIC(5y)7.4%
USAC Yearly ROA, ROE, ROICUSAC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100 200

1.3 Margins

  • USAC's Profit Margin of 10.32% is amongst the best of the industry. USAC outperforms 86.67% of its industry peers.
  • With an excellent Operating Margin value of 31.87%, USAC belongs to the best of the industry, outperforming 98.33% of the companies in the same industry.
  • In the last couple of years the Operating Margin of USAC has grown nicely.
  • USAC has a Gross Margin of 67.06%. This is amongst the best in the industry. USAC outperforms 98.33% of its industry peers.
  • USAC's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 31.87%
PM (TTM) 10.32%
GM 67.06%
OM growth 3Y9.24%
OM growth 5Y5.52%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.11%
GM growth 5Y-0.63%
USAC Yearly Profit, Operating, Gross MarginsUSAC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50 -50

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

1

2. USAC Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so USAC is still creating some value.
  • The number of shares outstanding for USAC has been increased compared to 1 year ago.
  • The number of shares outstanding for USAC has been increased compared to 5 years ago.
  • The debt/assets ratio for USAC is higher compared to a year ago.
USAC Yearly Shares OutstandingUSAC Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M
USAC Yearly Total Debt VS Total AssetsUSAC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B

2.2 Solvency

  • USAC has a debt to FCF ratio of 9.11. This is a negative value and a sign of low solvency as USAC would need 9.11 years to pay back of all of its debts.
  • USAC has a Debt to FCF ratio of 9.11. This is comparable to the rest of the industry: USAC outperforms 41.67% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 9.11
Altman-Z N/A
ROIC/WACC1.32
WACC7.83%
USAC Yearly LT Debt VS Equity VS FCFUSAC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M 1B 1.5B 2B 2.5B

2.3 Liquidity

  • USAC has a Current Ratio of 1.27. This is a normal value and indicates that USAC is financially healthy and should not expect problems in meeting its short term obligations.
  • USAC has a Current ratio of 1.27. This is in the lower half of the industry: USAC underperforms 78.33% of its industry peers.
  • USAC has a Quick Ratio of 1.27. This is a bad value and indicates that USAC is not financially healthy enough and could expect problems in meeting its short term obligations.
  • USAC has a worse Quick ratio (0.55) than 93.33% of its industry peers.
Industry RankSector Rank
Current Ratio 1.27
Quick Ratio 0.55
USAC Yearly Current Assets VS Current LiabilitesUSAC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. USAC Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an nice 12.99% over the past year.
  • USAC shows a small growth in Revenue. In the last year, the Revenue has grown by 5.01%.
  • USAC shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 8.37% yearly.
EPS 1Y (TTM)12.99%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%38.89%
Revenue 1Y (TTM)5.01%
Revenue growth 3Y12.31%
Revenue growth 5Y8.37%
Sales Q2Q%2.68%

3.2 Future

  • USAC is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 35.48% yearly.
  • USAC is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 12.04% yearly.
EPS Next Y66.76%
EPS Next 2Y43.52%
EPS Next 3Y35.48%
EPS Next 5YN/A
Revenue Next Year30.81%
Revenue Next 2Y18.21%
Revenue Next 3Y12.04%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
USAC Yearly Revenue VS EstimatesUSAC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 500M 1B
USAC Yearly EPS VS EstimatesUSAC Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 2 -2 -4 -6

More info and screens

Find the best growth stocksShow best growing peers

5

4. USAC Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 32.79 indicates a quite expensive valuation of USAC.
  • Compared to the rest of the industry, the Price/Earnings ratio of USAC is on the same level as its industry peers.
  • USAC's Price/Earnings ratio indicates a valuation a bit more expensive than the S&P500 average which is at 25.79.
  • USAC is valuated rather expensively with a Price/Forward Earnings ratio of 19.67.
  • Based on the Price/Forward Earnings ratio, USAC is valued a bit cheaper than 63.33% of the companies in the same industry.
  • USAC is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 23.80, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 32.79
Fwd PE 19.67
USAC Price Earnings VS Forward Price EarningsUSAC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, USAC is valued a bit more expensive than the industry average as 65.00% of the companies are valued more cheaply.
  • Based on the Price/Free Cash Flow ratio, USAC is valued a bit cheaper than the industry average as 71.67% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 14.93
EV/EBITDA 10.96
USAC Per share dataUSAC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 6

4.3 Compensation for Growth

  • USAC's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • The decent profitability rating of USAC may justify a higher PE ratio.
  • A more expensive valuation may be justified as USAC's earnings are expected to grow with 35.48% in the coming years.
PEG (NY)0.49
PEG (5Y)N/A
EPS Next 2Y43.52%
EPS Next 3Y35.48%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

6

5. USAC Dividend Analysis

5.1 Amount

  • USAC has a Yearly Dividend Yield of 7.71%, which is a nice return.
  • Compared to an average industry Dividend Yield of 1.04, USAC pays a better dividend. On top of this USAC pays more dividend than 100.00% of the companies listed in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.91, USAC pays a better dividend.
Industry RankSector Rank
Dividend Yield 7.71%

5.2 History

  • The dividend of USAC decreases each year by -3.54%.
  • USAC has paid a dividend for at least 10 years, which is a reliable track record.
  • USAC has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)-3.54%
Div Incr Years0
Div Non Decr Years11
USAC Yearly Dividends per shareUSAC Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5 2

5.3 Sustainability

  • USAC pays out 259.03% of its income as dividend. This is not a sustainable payout ratio.
DP259.03%
EPS Next 2Y43.52%
EPS Next 3Y35.48%
USAC Yearly Income VS Free CF VS DividendUSAC Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M -200M -400M -600M
USAC Dividend Payout.USAC Dividend Payout, showing the Payout Ratio.USAC Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

USAC Fundamentals: All Metrics, Ratios and Statistics

USA COMPRESSION PARTNERS LP

NYSE:USAC (3/19/2026, 6:30:00 PM)

28.53

+0.28 (+0.99%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryEnergy Equipment & Services
Earnings (Last)02-17
Earnings (Next)05-04
Inst Owners36.67%
Inst Owner Change6.36%
Ins Owners0.45%
Ins Owner Change0.39%
Market Cap4.14B
Revenue(TTM)998.10M
Net Income(TTM)103.03M
Analysts51.67
Price Target28.41 (-0.42%)
Short Float %3.41%
Short Ratio11.99
Dividend
Industry RankSector Rank
Dividend Yield 7.71%
Yearly Dividend2.19
Dividend Growth(5Y)-3.54%
DP259.03%
Div Incr Years0
Div Non Decr Years11
Ex-Date01-26
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)3.74%
Min EPS beat(2)-8.37%
Max EPS beat(2)15.86%
EPS beat(4)2
Avg EPS beat(4)-6.56%
Min EPS beat(4)-38.94%
Max EPS beat(4)15.86%
EPS beat(8)4
Avg EPS beat(8)0.31%
EPS beat(12)5
Avg EPS beat(12)-31.07%
EPS beat(16)6
Avg EPS beat(16)-54.03%
Revenue beat(2)0
Avg Revenue beat(2)-2.2%
Min Revenue beat(2)-2.36%
Max Revenue beat(2)-2.04%
Revenue beat(4)0
Avg Revenue beat(4)-1.71%
Min Revenue beat(4)-2.36%
Max Revenue beat(4)-0.62%
Revenue beat(8)0
Avg Revenue beat(8)-1.64%
Revenue beat(12)1
Avg Revenue beat(12)-1.2%
Revenue beat(16)3
Avg Revenue beat(16)-0.83%
PT rev (1m)3.17%
PT rev (3m)4.28%
EPS NQ rev (1m)-1.15%
EPS NQ rev (3m)0.59%
EPS NY rev (1m)6.57%
EPS NY rev (3m)19.22%
Revenue NQ rev (1m)7.2%
Revenue NQ rev (3m)7.2%
Revenue NY rev (1m)5.96%
Revenue NY rev (3m)25.4%
Valuation
Industry RankSector Rank
PE 32.79
Fwd PE 19.67
P/S 4.14
P/FCF 14.93
P/OCF 10.49
P/B N/A
P/tB N/A
EV/EBITDA 10.96
EPS(TTM)0.87
EY3.05%
EPS(NY)1.45
Fwd EY5.09%
FCF(TTM)1.91
FCFY6.7%
OCF(TTM)2.72
OCFY9.53%
SpS6.88
BVpS-0.78
TBVpS-2.07
PEG (NY)0.49
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA 3.93%
ROE N/A
ROCE 13.08%
ROIC 10.33%
ROICexc 10.37%
ROICexgc 11.23%
OM 31.87%
PM (TTM) 10.32%
GM 67.06%
FCFM 27.75%
ROA(3y)2.56%
ROA(5y)1.12%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)9.05%
ROIC(5y)7.4%
ROICexc(3y)9.06%
ROICexc(5y)7.4%
ROICexgc(3y)9.9%
ROICexgc(5y)8.16%
ROCE(3y)11.45%
ROCE(5y)9.36%
ROICexgc growth 3Y22.3%
ROICexgc growth 5Y16.39%
ROICexc growth 3Y23.81%
ROICexc growth 5Y17.51%
OM growth 3Y9.24%
OM growth 5Y5.52%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.11%
GM growth 5Y-0.63%
F-Score6
Asset Turnover0.38
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 9.11
Debt/EBITDA 4.19
Cap/Depr 41.18%
Cap/Sales 11.75%
Interest Coverage 250
Cash Conversion 65.39%
Profit Quality 268.84%
Current Ratio 1.27
Quick Ratio 0.55
Altman-Z N/A
F-Score6
WACC7.83%
ROIC/WACC1.32
Cap/Depr(3y)71.82%
Cap/Depr(5y)58.22%
Cap/Sales(3y)20.5%
Cap/Sales(5y)17.54%
Profit Quality(3y)199.34%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)12.99%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%38.89%
EPS Next Y66.76%
EPS Next 2Y43.52%
EPS Next 3Y35.48%
EPS Next 5YN/A
Revenue 1Y (TTM)5.01%
Revenue growth 3Y12.31%
Revenue growth 5Y8.37%
Sales Q2Q%2.68%
Revenue Next Year30.81%
Revenue Next 2Y18.21%
Revenue Next 3Y12.04%
Revenue Next 5YN/A
EBIT growth 1Y5.94%
EBIT growth 3Y22.68%
EBIT growth 5Y14.35%
EBIT Next Year143.32%
EBIT Next 3Y38.92%
EBIT Next 5YN/A
FCF growth 1Y102.95%
FCF growth 3Y29.89%
FCF growth 5Y8.51%
OCF growth 1Y15.51%
OCF growth 3Y14.8%
OCF growth 5Y6.1%

USA COMPRESSION PARTNERS LP / USAC Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for USA COMPRESSION PARTNERS LP?

ChartMill assigns a fundamental rating of 4 / 10 to USAC.


Can you provide the valuation status for USA COMPRESSION PARTNERS LP?

ChartMill assigns a valuation rating of 5 / 10 to USA COMPRESSION PARTNERS LP (USAC). This can be considered as Fairly Valued.


How profitable is USA COMPRESSION PARTNERS LP (USAC) stock?

USA COMPRESSION PARTNERS LP (USAC) has a profitability rating of 6 / 10.


What are the PE and PB ratios of USA COMPRESSION PARTNERS LP (USAC) stock?

The Price/Earnings (PE) ratio for USA COMPRESSION PARTNERS LP (USAC) is 32.79 and the Price/Book (PB) ratio is -36.76.


What is the financial health of USA COMPRESSION PARTNERS LP (USAC) stock?

The financial health rating of USA COMPRESSION PARTNERS LP (USAC) is 1 / 10.